betway必威登陆网址 (betway.com )学报››2023,Vol. 44››Issue (8): 636-640.DOI:10.3969/j.issn.2097-0005.2023.08.017
• 综述 •上一篇
收稿日期:
2023-03-19出版日期:
2023-08-25发布日期:
2023-09-14通讯作者:
李鸣作者简介:
吕昂,硕士研究生,研究方向:风湿免疫,内科学(风湿免疫学), E-mail:lvang18254888820@163.com。基金资助:
Ang LV1(), Yan ZHANG2, Ming LI3(
)
Received:
2023-03-19Online:
2023-08-25Published:
2023-09-14Contact:
Ming LI摘要:
近年来人口老龄化已经成为我国面临的重大社会问题之一,而疾病负担成为健康老龄化面临的挑战。免疫病的患病率和发病率也在逐年增长,对年龄相关性免疫疾病的研究迅速发展。了解老年人免疫病在发病机制,疾病模式临床和免疫学特征上的特点,在老年人免疫疾病诊治方面发挥重要的作用。为了满足日益增长的老年人口健康相关需求,给老年人提供更高的医疗技术服务水平,合理配置医疗资源,建立老年免疫病科并将其作为一个独立的亚专科极其重要。
吕昂, 张焱, 李鸣. 老年免疫病的研究现状[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(8): 636-640.
Ang LV, Yan ZHANG, Ming LI. Development of immunological diseases in the elderly[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2023, 44(8): 636-640.
1 | Fang EF, Xie C, Schenkel JA, et al. A research agenda for ageing in China in the 21st century (2nd edition): focusing on basic and translational research, long-term care, policy and social networks[J]. Ageing Res Rev, 2020, 64: 101174. |
2 | 施小明. 新形势下我国老年人口面临的主要公共卫生挑战[J]. 中华医学杂志, 2021, 101(44): 3613. |
3 | Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China[J]. Rheumatol Int, 2009, 29(5): 481. |
4 | Sun X, Zhen X, Hu X, et al. Osteoarthritis in the middle-aged and elderly in China: prevalence and influencing factors[J]. Int J Environ Res Public Health, 2019, 16(23): 4701. |
5 | Callahan LF, Cleveland RJ, Allen KD, et al. Racial/ethnic, socioeconomic, and geographic disparities in the epidemiology of knee and hip osteoarthritis[J]. Rheum Dis Clin North Am, 2021, 47(1): 1. |
6 | O'Neill TW, McCabe PS, McBeth J. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis[J]. Best Pract Res Clin Rheumatol, 2018, 32(2): 312. |
7 | Morales-Valencia J, David G. The contribution of physiological and accelerated aging to cancer progression through senescence-induced inflammation[J]. Front Oncol, 2021, 11: 747822. |
8 | Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?[J]. Ageing Res Rev, 2021, 71: 101422. |
9 | Cunha LL, Perazzio SF, Azzi J, et al. Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response[J]. Front Immunol, 2020, 11: 1748. |
10 | Watad A, Bragazzi NL, Adawi M, et al. Autoimmunity in the elderly: insights from basic science and clinics - a mini-review[J]. Gerontology, 2017, 63(6): 515. |
11 | Szekanecz Z, McInnes IB, Schett G, et al. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases[J]. Nat Rev Rheumatol, 2021, 17(10): 585. |
12 | Ventura MT, Casciaro M, Gangemi S, et al. Immunosenescence in aging: between immune cells depletion and cytokines up-regulation[J]. Clin Mol Allergy, 2017, 15: 21. |
13 | Lewkiewicz S, Chuang YL, Chou T. A mathematical model of the effects of aging on naive T cell populations and diversity[J]. Bull Math Biol, 2019, 81(7): 2783. |
14 | Salminen A. Feed-forward regulation between cellular senescence and immunosuppression promotes the aging process and age-related diseases[J]. Ageing Res Rev, 2021, 67: 101280. |
15 | Ligotti ME, Aiello A, Accardi G, et al. Analysis of T and NK cell subsets in the Sicilian population from young to supercentenarian: he role of age and gender[J]. Clin Exp Immunol, 2021, 205(2): 198. |
16 | Mittelbrunn M, Kroemer G. Hallmarks of T cell aging[J]. Nat Immunol, 2021, 22(6): 687. |
17 | Parish ST, Wu JE, Effros RB. Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes[J]. J Clin Immunol, 2010, 30(6): 798. |
18 | Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults[J]. Ageing Res Rev, 2013, 12(4): 1069. |
19 | Tavenier J, Rasmussen LJH, Houlind MB, et al. Alterations of monocyte NF-κB p65/RelA signaling in a cohort of older medical patients, age-matched controls, and healthy young adults[J]. Immun Ageing, 2020, 17(1): 25. |
20 | Wang X, Chacon LI, Derakhshandeh R, et al. Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials[J]. PLoS One, 2020, 15(8): e0237401. |
21 | De Mol J, Kuiper J, Tsiantoulas D, et al. The dynamics of B cell aging in health and disease[J]. Front Immunol, 2021, 12: 733566. |
22 | Khan SR, Van der Burgh AC, Peeters RP, et al. Determinants of serum immunoglobulin levels: a systematic review and meta-analysis[J]. Front Immunol, 2021, 12: 664526. |
23 | Yin J, Ibrahim S, Petersen F, et al. Autoimmunomic signatures of aging and age-related neurodegenerative diseases are associated with brain function and ribosomal proteins[J]. Front Aging Neurosci, 2021, 13: 679688. |
24 | Andersen-Ranberg K, HØier-Madsen M, Wiik A, et al. High prevalence of autoantibodies among Danish centenarians[J]. Clin Exp Immunol, 2004, 138(1): 158. |
25 | Vadasz Z, Haj T, Kessel A, et al. Age-related autoimmunity[J]. BMC Med, 2013, 11: 94. |
26 | Baban B, Khodadadi H, Salles ÉL, et al. Inflammaging and cannabinoids[J]. Ageing Res Rev, 2021, 72: 101487. |
27 | Martínez De Toda I, Ceprián N, Díaz-Del Cerro E, et al. The role of immune cells in oxi-inflamm-aging[J]. Cells, 2021, 10(11): 2974. |
28 | Fulop T, Larbi A, Pawelec G, et al. Immunology of aging: the birth of inflammaging[J]. Clin Rev Allergy Immunol, 2023, 64(2): 109. |
29 | Sohn IW, Joo YB, Won S, et al. Late-onset systemic lupus erythematosus: is it "mild lupus"?[J]. Lupus, 2018, 27(2): 235. |
30 | Chanprapaph K, Tubtieng I, Pratumchat N, et al. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients[J]. Lupus, 2021, 30(5): 785. |
31 | Medhat BM, Behiry ME, Sobhy N, et al. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort[J]. Clin Rheumatol, 2020, 39(2): 435. |
32 | Huang Y, Wu X, Gui L, et al. Age-specific imbalance of circulating Tfh cell subsets and its association with gout-targeted kidney impairment[J]. Front Immunol, 2021, 11: 625458. |
33 | Chang PY, Chang YW, Lin YF, et al. Sex-specific association of uric acid and kidney function decline in Taiwan[J]. J Pers Med, 2021, 11(5): 415. |
34 | Kumar M, Manley N, Mikuls TR. Gout flare burden, diagnosis, and management: navigating care in older patients with comorbidity[J]. Drugs Aging, 2021, 38(7): 545. |
35 | Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors[J]. Nat Rev Rheumatol, 2020, 16(7): 380. |
36 | Huang WS, Lin CL, Tsai CH, et al. Association of gout with CAD and effect of antigout therapy on CVD risk among gout patients[J]. J Investig Med, 2020, 68(5): 972. |
37 | Suh YS, Noh HS, Kim HJ, et al. Differences in clinical and dietary characteristics, serum adipokine levels, and metabolomic profiles between early- and late-onset gout[J]. Metabolites, 2021, 11(6): 399. |
38 | Wan Ghazali WS, Wan Zainudin WMKB, Yahya NK, et al. Older age and diclofenac are associated with increased risk of upper gastrointestinal bleeding in gout patients[J]. PeerJ, 2021, 9: e11468. |
39 | Serhal L, Lwin MN, Holroyd C, et al. Rheumatoid arthritis in the elderly: characteristics and treatment considerations[J]. Autoimmun Rev, 2020, 19(6): 102528. |
40 | Kumagai K, Okumura N, Amano Y, et al. Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity[J]. Mod Rheumatol, 2021, 31(6): 1094. |
[1] | 褚微, 张冰, 纪洪.HMGCS2在疾病中的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(7): 546-551. |
[2] | 于焕君, 党和勤, 周国庆, 耿彪.1例奋乃静致迟发性肌张力障碍患者的药学监护[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(12): 938-941. |
[3] | 廖杰, 杜以梅.术后心房颤动发病机制的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(12): 891-896. |
[4] | 王伟.动脉瘤性蛛网膜下腔出血患者脑脊液MIF水平与迟发性脑缺血的关系[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(1): 46-48. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||